Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Dexamethasone × Other × Clear all

Phase

Status

Unknown 2 Withdrawn 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 326 Lymphoid 174 Other hematologic neoplasm 123 Genitourinary 21 Gastrointestinal 20 Gynecologic 13 Thoracic 12 Breast 12 Head & Neck 10 Sarcoma 9 Tumor-Agnostic 8 CNS 8 Dermatologic 7 Myeloid 5 Other solid neoplasm 4 Classical hematology 4 Other neoplasm 1 Other 1 Endocrine 1

Conditions

Hematologic Diseases 1 Dyspnea 1

Interventions

Exercise 14 Surveys and Questionnaires 10 Metformin 10 Methods 7 Radiotherapy 6 Psychiatric Rehabilitation 5 Nutrition Assessment 5 Exenatide 5 Early Intervention, Educational 5 Diet 5 naloxegol 4 alvimopan 4 Educational Status 4 Diet Therapy 4 Counseling 4 Sugars 3 Standard of Care 3 Resistance Training 3 Interviews as Topic 3 Injections 3 Fibroblast Growth Factor 7 3 Drug Therapy 3 Caloric Restriction 3 exemestane 2 Yoga 2 Xylitol 2 Water 2 Vitamin D 2 Therapeutics 2 Testosterone Propionate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01670097 2021-02-17

Dexamethasone Dyspnea Study

M.D. Anderson Cancer Center

Phase 2 Completed

52 enrolled 13 charts

Dyspnea, Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡